Nick Torres focuses his practice on health care transactional, regulatory, and compliance matters. Prior to joining Mintz, Nick was an associate with a law firm in New York City, where he was a member of the M&A, SPAC, and China practices. He participated in all phases of M&A transactions, led the due diligence team, prepared agreements, and participated in negotiations. He also participated throughout the SPAC listing process, representing both issuers and underwriters. In addition, Nick advised clients in IPO deals with China-based issuers and in private M&A deals with Chinese companies. Earlier, working in Beijing, Nick was a member of another firm’s cross-border M&A team specializing in Chinese outbound transactions. In that role, Nick advised clients on global M&A deals, representing Chinese acquirers in acquisitions of overseas entities. His experience included advising a global private equity firm on its 100% acquisition of a multinational semiconductor company and advising a leading private equity fund on its equity round (Series A and Series B) investments in the technology, media, and telecom sector. Nick has lectured on topics of interest to entrepreneurs, including venture capital financing, at venues including the Wuhan University of Technology and Haidian Pioneer Park, an incubator in Beijing. He has also participated in training webinars with Startup Grind Beijing.
342
A few days ago, the State Administration for Market Regulation (“SAMR”) and Shanghai Administration for Market Regulation (“Shanghai AMR”) successively issued two administrative decisions punishing two Internet platform companies for engaging in “either-or choice” practices (a type of exclusive (...)
34
This article has been nominated for the 2021 Antitrust Writing Awards. Click here to learn more about the Antitrust Writing Awards. On 10 November, the Anti-Monopoly Bureau of the State Administration for Market Regulation (“SAMR”) issued the Antitrust Guidelines for the Platform Economic (...)
128
China’s IP Antitrust Guidelines Released to the Public* Preface Recently, the Anti-Monopoly Guidelines for the Intellectual Property (“IP Guidelines”) was published in the Collection of Antitrust Regulations and Guidelines in 2019 released by the Anti-Monopoly Bureau of the State Administration (...)
384
For the past three years (2017–2020), it appears that conglomerate mergers were under more scrutiny in China than in the European Union (“EU”) or the United States (“U.S.”). This article mainly examines five mergers—namely, HP/Samsung, Essilor/Luxottica, KLA/Orbotech, Infineon/Cypress and (...)
19 avenue Jean Aicard
75011 Paris, France
106 West 32nd Street, Suite 149
New York, NY, 10001, USA
563 Chiswick High Road
W4 3AY London, UK
